Developing a Clear Path Forward for Non-Clear-Cell Renal Carcinoma

被引:2
作者
Pal, Sumanta K. [1 ]
Karam, Jose A. [2 ]
Bergerot, Paulo [3 ]
Agarwal, Neeraj [4 ]
机构
[1] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Fed Sao Paulo, Sao Paulo, Brazil
[4] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
关键词
PHASE-II; OPEN-LABEL; EVEROLIMUS; BEVACIZUMAB; TRIAL; MULTICENTER; MUTATIONS; THERAPY; MTOR; MET;
D O I
10.1200/JCO.2016.69.3572
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3825 / +
页数:3
相关论文
共 17 条
[1]   MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array [J].
Albiges, Laurence ;
Guegan, Justine ;
Le Formal, Audrey ;
Verkarre, Virginie ;
Rioux-Leclercq, Nathalie ;
Sibony, Mathilde ;
Bernhard, Jean-Christophe ;
Camparo, Philippe ;
Merabet, Zahira ;
Molinie, Vincent ;
Allory, Yves ;
Orear, Cedric ;
Couve, Sophie ;
Gad, Sophie ;
Patard, Jean-Jacques ;
Escudier, Bernard .
CLINICAL CANCER RESEARCH, 2014, 20 (13) :3411-3421
[2]   Everolimus versus sunitinib for patients with metastatic non-clear-cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial [J].
Armstrong, Andrew J. ;
Halabi, Susan ;
Eisen, Tim ;
Broderick, Samuel ;
Stadler, Walter M. ;
Jones, Robert J. ;
Garcia, Jorge A. ;
Vaishampayan, Ulka N. ;
Picus, Joel ;
Hawkins, Robert E. ;
Hainsworth, John D. ;
Kollmannsberger, Christian K. ;
Logan, Theodore F. ;
Puzanov, Igor ;
Pickering, Lisa M. ;
Ryan, Christopher W. ;
Protheroe, Andrew ;
Lusk, Christine M. ;
Oberg, Sadie ;
George, Daniel J. .
LANCET ONCOLOGY, 2016, 17 (03) :378-388
[3]   Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance [J].
Berns, Katrien ;
Sonnenblick, Amir ;
Gennissen, Annemiek ;
Brohee, Sylvain ;
Hijmans, E. Marielle ;
Evers, Bastiaan ;
Fumagalli, Debora ;
Desmedt, Christine ;
Loibl, Sibylle ;
Denkert, Carsten ;
Neven, Patrick ;
Guo, Wei ;
Zhang, Fan ;
Knijnenburg, Theo A. ;
Bosse, Tjalling ;
van der Heijden, Michiel S. ;
Hindriksen, Sanne ;
Nijkamp, Wouter ;
Wessels, Lodewyk F. A. ;
Joensuu, Heikki ;
Mills, Gordon B. ;
Beijersbergen, Roderick L. ;
Sotiriou, Christos ;
Bernards, Rene .
CLINICAL CANCER RESEARCH, 2016, 22 (21) :5238-5248
[4]   Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling [J].
Chandler, Ronald L. ;
Damrauer, Jeffrey S. ;
Raab, Jesse R. ;
Schisler, Jonathan C. ;
Wilkerson, Matthew D. ;
Didion, John P. ;
Starmer, Joshua ;
Serber, Daniel ;
Yee, Della ;
Xiong, Jessie ;
Darr, David B. ;
de Villena, Fernando Pardo-Manuel ;
Kim, William Y. ;
Magnuson, Terry .
NATURE COMMUNICATIONS, 2015, 6
[5]   The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma [J].
Davis, Caleb F. ;
Ricketts, Christopher J. ;
Wang, Min ;
Yang, Lixing ;
Cherniack, Andrew D. ;
Shen, Hui ;
Buhay, Christian ;
Kang, Hyojin ;
Kim, Sang Cheol ;
Fahey, Catherine C. ;
Hacker, Kathryn E. ;
Bhanot, Gyan ;
Gordenin, Dmitry A. ;
Chu, Andy ;
Gunaratne, Preethi H. ;
Biehl, Michael ;
Seth, Sahil ;
Kaipparettu, Benny A. ;
Bristow, Christopher A. ;
Donehower, Lawrence A. ;
Wallen, Eric M. ;
Smith, Angela B. ;
Tickoo, Satish K. ;
Tamboli, Pheroze ;
Reuter, Victor ;
Schmidt, Laura S. ;
Hsieh, James J. ;
Choueiri, Toni K. ;
Hakimi, A. Ari ;
Chin, Lynda ;
Meyerson, Matthew ;
Kucherlapati, Raju ;
Park, Woong-Yang ;
Robertson, A. Gordon ;
Laird, Peter W. ;
Henske, Elizabeth P. ;
Kwiatkowski, David J. ;
Park, Peter J. ;
Morgan, Margaret ;
Shuch, Brian ;
Muzny, Donna ;
Wheeler, David A. ;
Linehan, W. Marston ;
Gibbs, Richard A. ;
Rathmell, W. Kimryn ;
Creighton, Chad J. ;
Signoretti, Sabina ;
Seiler, Michael ;
Chao, Hsu ;
Dahdouli, Mike .
CANCER CELL, 2014, 26 (03) :319-330
[6]   Phase II Trial of Bevacizumab and Everolimus in Patients With Advanced Renal Cell Carcinoma [J].
Hainsworth, John D. ;
Spigel, David R. ;
Burris, Howard A., III ;
Waterhouse, David ;
Clark, Bobby L. ;
Whorf, Robert .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2131-2136
[7]   A Phase II Study of Bevacizumab and Everolimus as Treatment for Refractory Metastatic Renal Cell Carcinoma [J].
Harshman, Lauren C. ;
Barbeau, Sarah ;
McMillian, Alex ;
Srinivas, Sandy .
CLINICAL GENITOURINARY CANCER, 2013, 11 (02) :100-106
[8]   Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma [J].
Kwiatkowski, David J. ;
Choueiri, Toni K. ;
Fay, Andre P. ;
Rini, Brian I. ;
Thorner, Aaron R. ;
de Velasco, Guillermo ;
Tyburczy, Magdalena E. ;
Hamieh, Lana ;
Albiges, Laurence ;
Agarwal, Neeraj ;
Ho, Thai H. ;
Song, Jiaxi ;
Pignon, Jean-Christophe ;
Barrios, Pablo M. ;
Michaelson, M. Dror ;
Van Allen, Eliezer M. ;
Krajewski, Katherine M. ;
Porta, Camillo ;
Pal, Sumanta Kumar ;
Bellmunt, Joaquim ;
McDermott, David F. ;
Heng, Daniel Y. C. ;
Gray, Kathryn P. ;
Signoretti, Sabina .
CLINICAL CANCER RESEARCH, 2016, 22 (10) :2445-2452
[9]   Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma [J].
Linehan, W. Marston ;
Spellman, Paul T. ;
Ricketts, Christopher J. ;
Creighton, Chad J. ;
Fei, Suzanne S. ;
Davis, Caleb ;
Wheeler, David A. ;
Murray, Bradley A. ;
Schmidt, Laura ;
Vocke, Cathy D. ;
Peto, Myron ;
Al Mamun, Abu Amar M. ;
Shinbrot, Eve ;
Sethi, Anurag ;
Brooks, Samira ;
Rathmell, W. Kimryn ;
Brooks, Angela N. ;
Hoadley, Katherine A. ;
Robertson, A. Gordon ;
Brooks, Denise ;
Bowlby, Reanne ;
Sadeghi, Sara ;
Shen, Hui ;
Weisenberger, Daniel J. ;
Bootwalla, Moiz ;
Baylin, Stephen B. ;
Laird, Peter W. ;
Cherniack, Andrew D. ;
Saksena, Gordon ;
Haake, Scott ;
Li, Jun ;
Liang, Han ;
Lu, Yiling ;
Mills, Gordon B. ;
Akbani, Rehan ;
Leiserson, Mark D. M. ;
Raphael, Benjamin J. ;
Anur, Pavana ;
Bottaro, Donald ;
Albiges, Laurence ;
Barnabas, Nandita ;
Choueiri, Toni K. ;
Czerniak, Bogdan ;
Godwin, Andrew K. ;
Hakimi, A. Ari ;
Ho, Thai H. ;
Hsieh, James ;
Ittmann, Michael ;
Kim, William Y. ;
Krishnan, Bhavani .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (02) :135-145
[10]   Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial [J].
Motzer, Robert J. ;
Hutson, Thomas E. ;
Glen, Hilary ;
Michaelson, M. Dror ;
Molina, Ana ;
Eisen, Timothy ;
Jassem, Jacek ;
Zolnierek, Jakub ;
Pablo Maroto, Jose ;
Mellado, Begona ;
Melichar, Bohuslav ;
Tomasek, Jiri ;
Kremer, Alton ;
Kim, Han-Joo ;
Wood, Karen ;
Dutcus, Corina ;
Larkin, James .
LANCET ONCOLOGY, 2015, 16 (15) :1473-1482